Molecular mechanisms of retinogeniculate circuit formation
Molecular mechanisms of retinogeniculate circuit formation
批准号:
10192727
负责人:
MICHAEL A FOX
金额:
$36.84万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2023-06-30
关键词:
AffectAmericanAnatomyAxonBlindnessBrainBrain regionCandidate Disease GeneCell NucleusCellsCoculture TechniquesComplexCuesDataDendritesDependovirusDevelopmentDiseaseDorsalEconomic BurdenElectrophysiology (science)Eye diseasesFosteringFundingGenesGlaucomaGoalsGrowthHistologicIGF1R geneImmunohistochemistryIn VitroIndividualInjectionsInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorInterneuronsKnowledgeLabelLateral Geniculate BodyLeucine-Rich RepeatMindMolecularMolecular GeneticsMusNational Eye InstituteNatural regenerationNerveNerve DegenerationNeurogliaNeuronsPatientsPersonsPhenotypePhysiologicalPopulationProteinsRecombinant IGF-IRecombinantsReporterResearchRetinaRetinal Ganglion CellsRoleSignal TransductionSomatomedinsSwimmingSynapsesTechniquesTestingThalamic structureTransgenic OrganismsValidationViralVisionVisualVisual impairmentWorkage relatedbasecostdesigneffective therapyexperimental studymutantnovelregenerative therapyrelating to nervous systemresponseretinal axonretinogeniculatesight restorationsocialsuperior colliculus Corpora quadrigeminasynaptogenesistranscriptome sequencingviral rescuevisual information
中文摘要
影响视力的发育和年龄相关疾病给老年人带来了重大的社会和经济负担
美国经济。其中许多疾病特别影响连接视网膜的神经元(即视网膜神经节
细胞[RGCs])信息传给大脑。这些疾病中最常见的是青光眼,一种进行性青光眼
神经退行性眼病是美国不可逆转失明的主要原因。目前,有3个
数百万美国人患有青光眼,每年给美国经济造成近30亿美元的损失。
青光眼并不是唯一影响视网膜节细胞的疾病。目前还没有对患者有效的治疗方法
患有青光眼。为了回应这一未得到满足的需求,NEI发布了一个目标,即获得新的知识,将
帮助开发旨在恢复视网膜和视网膜之间连接的再生疗法
大脑。为了实现这一目标,我们需要更好地了解推动形成
在正常发育过程中的这些连接。在过去的5年里,我们研究了
推动视网膜轴突生长到大脑中适当的靶区。在这项工作中,我们发现
背外侧膝状核(DLGN)内的视网膜突触在解剖学和功能上与
视网膜突触存在于所有其他视网膜受体区域。因为这些突触对于传递视觉是至关重要的
信息传递到大脑皮层,了解它们的形成机制对于恢复皮质下视觉至关重要
电路功能。考虑到这一点,本应用程序的目标是识别目标派生的线索
负责dLGN中视黄素原性突触的独特发育。初步实验
鉴定的胰岛素样生长因子1和富亮氨酸重复序列跨膜神经元蛋白1
(LRRTM1)作为两个突触信号在dLGN中表达。这里将使用分子、遗传学、解剖学和
评估这些分子在视网膜生成回路形成中的作用的生理学方法。
英文摘要
Developmental and age-related disorders that affect vision impart a major social and economic burden on the
US economy. Many of these disorders specifically affect neurons that connect the retina (i.e., retinal ganglion
cells [RGCs]) information to the brain. The most common of these disorders is glaucoma, a progressive
neurodegenerative eye disorder that is the leading cause of irreversible blindness in the US. Currently, 3
million Americans are living with glaucoma, costing the US economy nearly 3 billion dollars each year.
Glaucoma is not the only disorder that impacts RGCs. Currently there are no effective treatments for patients
with glaucoma. In response to this unmet need, NEI has issued a goal of gaining new knowledge that will
contribute to the development of regenerative therapies aimed at restoring connections between the retina and
brain. To accomplish this goal, we need a better understanding of the mechanisms that drive the formation of
these connections during normal development. Over the past 5 years, we investigated the mechanisms that
drive the growth of retinal axons into appropriate target regions of brain. During this work, we discovered that
retinal synapses in the dorsal lateral geniculate nucleus (dLGN) are anatomically and functionally distinct from
retinal synapses in all other retino-recipient regions. Because these synapses are crucial for transmitting visual
information to cortex, understanding mechanisms of their formation is essential for restoring subcortical visual
circuit function. With this in mind, the objective of this application aims to identify target-derived cues
responsible for the unique development of retinogeniculate synapses in dLGN. Preliminary experiments
identified Insulin-like Growth Factor 1 (IGF1) and Leucine-Rich Repeat Transmembrane Neuronal Protein 1
(LRRTM1) as two synaptogenic cues expressed in dLGN. Here will will use molecular, genetic, anatomical and
physiological approaches to assess roles of these molecules in retinogeniculate circuit formation.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1083/jcb.201509085
发表时间:
2016-03-14
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Su J, Chen J, Lippold K, Monavarfeshani A, Carrillo GL, Jenkins R, Fox MA]
通讯作者:
Fox MA
DOI:
10.3389/fnint.2017.00020
发表时间:
2017
期刊:
Frontiers in integrative neuroscience
影响因子:
3.5
作者:
[Monavarfeshani A, Knill CN, Sabbagh U, Su J, Fox MA]
通讯作者:
Fox MA
Retinal inputs signal through astrocytes to recruit interneurons into visual thalamus
-
批准号:9806328
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2019
-
负责人:MICHAEL A FOX
-
依托单位:
Virginia Tech Carilion Research Institute Translational Neurobiology Summer Undergraduate Research Fellowship (VTCRI neuroSURF)
-
批准号:10320012
-
项目类别:
-
资助金额:$10.77万
-
财政年份:2018
-
负责人:MICHAEL A FOX
-
依托单位:
Virginia Tech Carilion Research Institute Translational Neurobiology Summer Undergraduate Research Fellowship (VTCRI neuroSURF)
-
批准号:9925879
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2018
-
负责人:MICHAEL A FOX
-
依托单位:
Regulation of nuclei-specific retinogeniculate targeting
-
批准号:8024000
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2011
-
负责人:MICHAEL A FOX
-
依托单位:
Regulation of nuclei-specific retinogeniculate targeting
-
批准号:8722562
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2011
-
负责人:MICHAEL A FOX
-
依托单位:
Molecular mechanisms of retinogeniculate circuit formation
-
批准号:9549105
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2011
-
负责人:MICHAEL A FOX
-
依托单位:
Regulation of nuclei-specific retinogeniculate targeting
-
批准号:8316108
-
项目类别:
-
资助金额:$8.59万
-
财政年份:2011
-
负责人:MICHAEL A FOX
-
依托单位:
Regulation of nuclei-specific retinogeniculate targeting
-
批准号:8606304
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2011
-
负责人:MICHAEL A FOX
-
依托单位:
Regulation of nuclei-specific retinogeniculate targeting
-
批准号:8535773
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2011
-
负责人:MICHAEL A FOX
-
依托单位:
Functional analysis of PD-l alpha/ATX in the CNS
-
批准号:6619490
-
项目类别:
-
资助金额:$2.84万
-
财政年份:2002
-
负责人:MICHAEL A FOX
-
依托单位:
Functional analysis of PD-l alpha/ATX in the CNS
-
批准号:6552783
-
项目类别:
-
资助金额:$2.66万
-
财政年份:2002
-
负责人:MICHAEL A FOX
-
依托单位:
海外基金